Bruker (NASDAQ:BRKR) Issues Q1 2021 Earnings Guidance


Share on StockTwits

Bruker (NASDAQ:BRKR) updated its first quarter 2021 earnings guidance on Tuesday. The company provided EPS guidance of – for the period. The company issued revenue guidance of $549 million-$554 million, compared to the consensus revenue estimate of $506.86 million.

Several analysts recently issued reports on the stock. Stifel Nicolaus upped their price objective on shares of Bruker from $48.00 to $65.00 and gave the company a hold rating in a research note on Wednesday, February 17th. Wells Fargo & Company cut shares of Bruker from an overweight rating to an equal weight rating and upped their price objective for the company from $50.00 to $55.00 in a research note on Friday, February 5th. SVB Leerink boosted their target price on shares of Bruker from $50.00 to $70.00 and gave the company an outperform rating in a report on Wednesday, January 27th. Finally, Citigroup boosted their target price on shares of Bruker from $57.00 to $65.00 in a report on Wednesday, February 17th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company. Bruker currently has an average rating of Hold and an average target price of $59.11.

BRKR traded down $0.11 during trading hours on Tuesday, hitting $68.54. 451,117 shares of the company’s stock were exchanged, compared to its average volume of 471,442. Bruker has a 12-month low of $35.98 and a 12-month high of $70.62. The firm has a 50 day moving average of $65.78 and a 200 day moving average of $57.15. The firm has a market cap of $10.39 billion, a P/E ratio of 67.00, a price-to-earnings-growth ratio of 7.11 and a beta of 1.29. The company has a current ratio of 2.67, a quick ratio of 1.65 and a debt-to-equity ratio of 0.86.

Bruker (NASDAQ:BRKR) last announced its earnings results on Monday, February 15th. The medical research company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.56 by $0.02. Bruker had a net margin of 8.04% and a return on equity of 21.78%. The firm had revenue of $627.50 million for the quarter, compared to the consensus estimate of $624.80 million. As a group, research analysts expect that Bruker will post 1.33 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 19th. Shareholders of record on Friday, March 5th were given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.23%. The ex-dividend date was Thursday, March 4th. Bruker’s dividend payout ratio is presently 10.19%.

In other Bruker news, Director Cynthia M. Friend sold 1,800 shares of the stock in a transaction that occurred on Monday, March 22nd. The shares were sold at an average price of $60.43, for a total value of $108,774.00. Following the sale, the director now directly owns 10,486 shares of the company’s stock, valued at approximately $633,668.98. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 26.80% of the company’s stock.

About Bruker

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.

Featured Article: Dividend Kings

Earnings History and Estimates for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.